Study ID: CTSU C80803
Description:

Randomized Phase II Trial Of Pet Scan-Directed Combined Modality Therapy In Esophageal Cancer

Location:
Fargo Region
Principal Investigator:
Preston Steen MD
Disease:
Esophagus
Stage:
Phase II

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list